The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 20, 2026
Filed:
Jul. 30, 2020
Applicant:
Eikonizo Therapeutics, Inc., Beverly, MA (US);
Inventors:
Florence Fevrier Wagner, Cambridge, MA (US);
Jacob Matthew Hooker, Winchester, MA (US);
Stéphane Ouellet, Sudbury, MA (US);
Assignee:
Eikonizo Therapeutics, Inc., Cambridge, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 205/12 (2006.01); A61P 25/00 (2006.01); A61P 25/28 (2006.01); A61P 29/00 (2006.01); A61P 31/00 (2006.01); A61P 35/00 (2006.01); A61P 37/00 (2006.01); C07D 207/06 (2006.01); C07D 209/08 (2006.01); C07D 209/54 (2006.01); C07D 209/96 (2006.01); C07D 217/04 (2006.01); C07D 221/20 (2006.01); C07D 221/22 (2006.01); C07D 237/30 (2006.01); C07D 267/10 (2006.01); C07D 295/15 (2006.01); C07D 405/04 (2006.01); C07D 405/06 (2006.01); C07D 451/02 (2006.01); C07D 451/06 (2006.01); C07D 471/04 (2006.01); C07D 471/08 (2006.01); C07D 471/10 (2006.01); C07D 487/04 (2006.01); C07D 491/08 (2006.01); C07D 491/107 (2006.01); C07D 493/04 (2006.01); C07D 493/08 (2006.01); C07D 498/04 (2006.01); C07D 498/08 (2006.01); C07D 498/18 (2006.01);
U.S. Cl.
CPC ...
C07D 205/12 (2013.01); C07D 209/08 (2013.01); C07D 217/04 (2013.01); C07D 237/30 (2013.01); C07D 405/04 (2013.01); C07D 451/06 (2013.01); C07D 471/04 (2013.01); C07D 487/04 (2013.01); C07D 491/08 (2013.01); C07D 491/107 (2013.01); C07D 493/08 (2013.01); C07D 498/04 (2013.01);
Abstract
Provided herein are compounds that inhibit HDAC6, a protein whose activity is associated with a variety of diseases (e.g., cancer, neurological disorders). Also provided are pharmaceutical compositions and kits comprising the compounds, and methods of treating HDAC6-related diseases and disorders (e.g., Alzheimer's disease, cancer) with the compounds in a subject, by administering the compounds and/or compositions described herein.